China is in talks with WHO

China in talks with WHO

Celestial Empire expects to receive approval of its COVID-19 vaccines for global use.

China in talks with WHO

A WHO spokesman said on Tuesday that China is in talks to have its locally produced COVID-19 vaccines evaluated by the World Health Organization in order to make them available for international use..

Hundreds of thousands of populations considered to be at high risk of infection in China received locally produced vaccines, even though clinical trials have not been fully completed, raising concern among experts.

Socorro Escalate, WHO Focal Point for Essential Medicines and Health Technologies in the Western Pacific Region, said in an internet press conference that China had preliminary discussions with WHO on whether its vaccines would be listed for emergency use.

WHO’s Emergency Use Listing process enables the evaluation of unlicensed vaccines and treatments to accelerate their availability in public health emergencies. It helps WHO Member States and UN procurement agencies to determine the acceptability of vaccines.

«The potential for this emergency use will be to assess the quality and safety of these vaccines, as well as their effectiveness. ..and then they will become available to our licensees», – said Escalante.

In China, at least four experimental vaccines are in the final stages of clinical trials – two developed by the state-sponsored China National Biotec Group (CNBG), and the remaining two from Sinovac Biotech and CanSino Biologics..

They are being tested in countries such as Pakistan, Indonesia, Brazil, Russia and the United Arab Emirates.

Last month, the UAE authorized the emergency use of the CNBG vaccine, giving the first international approval for one of the Chinese vaccines. It happened just six weeks after the start of human trials in this Arab state of the Persian Gulf..

President of the Philippines Rodrigo Duterte said last month that China and Russia will be a priority in global vaccine procurement for his country.

Popular